...
首页> 外文期刊>Der Pharma Chemica: journal for medicinal chemistry, pharmaceutical chemistry and computational chemistry >Synthesis and evaluation of antibacterial activity of some new N,Na??-(5-(6-(4-substitutedphenyl)imidazo[2,1-b][1,3,4]-thiadiazol-2-yl)- pyrimidine-2,4-diyl)diacetamide derivatives
【24h】

Synthesis and evaluation of antibacterial activity of some new N,Na??-(5-(6-(4-substitutedphenyl)imidazo[2,1-b][1,3,4]-thiadiazol-2-yl)- pyrimidine-2,4-diyl)diacetamide derivatives

机译:一些新的N,Na +-(5-(6-(4-(4-取代苯基)咪唑并[2,1-b] [1,3,4]-噻二唑-2-基)-嘧啶的合成及抗菌活性评价-2,4-二基)二乙酰胺衍生物

获取原文
           

摘要

A series of new N,N’-(5-(6-(4-substitutedphenyl)imidazo[2,1-b][1,3,4]-thiadiazol-2- yl)pyrimidine-2,4-diyl)diacetamide derivatives were synthesized and tested for their antibacterial activity. Guanidine carbonate & ethyl (ethoxymethylene) cyanoacetate are used as the starting materials for the preparation of ethyl-2, 4-Diaminopyrimidine-5-carboxylate (I). The reactive amino groups are acetylated using acetic anhydride in presence of DMF to form ethyl 2, 4- diacetamidopyrimidine-5-carboxylate (Ia). Efforts without masking the reactive amino groups on pyrimidine at this stage did not yield the target compounds. Further ethyl group from position 5 is removed as ethanol by refluxing Ia with 10% alcoholic NaOH for 10min to form 2, 4- diacetamidopyrimidine-5-carboxylic acid (IIa). Hence formed acid is refluxed for 4 hours with thiosemicarbazide and phosphorous oxychloride to get N, N’-(5-(5-amino-1, 3, 4-thiadiazol-2-yl) pyrimidine-2, 4-diyl) diacetamide (IIIa). Further target compounds were synthesized using different substituted phenacyl bromides. The structures of the newly synthesized compounds were confirmed by IR and 1H NMR spectroscopy. All the synthesized compounds were tested for their antibacterial activities using cup-plate-agar-diffusion method. Result of antibacterial activity reveals that the compounds IVb, IVe and IVf have shown potent activity against both grampositive and gram-negative microorganisms as compared to the standard drug methotrexate.
机译:一系列新的N,N'-(5-(6-(4-取代的苯基)咪唑[2,1-b] [1,3,4]-噻二唑-2-基)嘧啶-2,4-二基)合成了二乙酰胺衍生物,并测试了它们的抗菌活性。碳酸胍和(乙氧基亚甲基)氰基乙酸乙酯用作制备2-,4-二氨基嘧啶-5-羧酸乙酯(I)的原料。在DMF的存在下,使用乙酸酐将反应性氨基乙酰化,以形成2,4-二乙酰氨基嘧啶-5-羧酸乙酯(Ia)。在该阶段不掩盖嘧啶上的反应性氨基的努力没有得到目标化合物。通过将Ia与10%醇NaOH回流10分钟以形成2,4-二乙酰胺基嘧啶-5-羧酸(IIa),从位置5进一步除去乙基作为乙醇。将生成的酸与硫代氨基脲和三氯氧化磷回流4小时,得到N,N'-(5-(5-氨基-1,3,4-噻二唑-2-基)嘧啶-2,4-二基)二乙酰胺( IIIa)。使用不同的取代的苯甲酰溴合成了其他目标化合物。通过IR和1H NMR光谱确认了新合成的化合物的结构。使用杯板琼脂扩散法测试所有合成的化合物的抗菌活性。抗菌活性的结果表明,与标准药物甲氨蝶呤相比,化合物IVb,IVe和IVf对革兰氏阳性和革兰氏阴性微生物均显示出强大的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号